Adverse clinical outcomes and distinct genomic phenotype of BRCA-deficient metastatic castration-resistant prostate cancer (mCRPC)

被引:0
|
作者
Fettke, Heidi
Dai, Chao
Kwan, Edmond M.
Zheng, Tiantian
Tan, Winston
Du, P.
Ng, Nicole
Bukszynska, Patricia
Docanto, Maria
Graham, L. K.
Mahon, Kate
Horvath, Lisa G.
Jia, Shidong
Kohli, Manish
Azad, Arun A.
机构
关键词
D O I
10.1158/1538-7445.AM2023-2303
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2303
引用
收藏
页数:2
相关论文
共 50 条
  • [1] BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype
    Fettke, Heidi
    Dai, Chao
    Kwan, Edmond M.
    Zheng, Tiantian
    Du, Pan
    Ng, Nicole
    Bukczynska, Patricia
    Docanto, Maria
    Kostos, Louise
    Foroughi, Siavash
    Brown, Stephen
    Graham, Lisa-Jane K.
    Mahon, Kate
    Horvath, Lisa G.
    Jia, Shidong
    Kohli, Manish
    Azad, Arun A.
    EBIOMEDICINE, 2023, 95
  • [2] Body composition and clinical outcomes in men with metastatic castration-resistant prostate cancer (mCRPC)
    Hahn, A. W.
    Tidwell, R. S.
    Surasi, D. S.
    Msaouel, P.
    Efstathiou, E.
    Zurita-Saavedra, A. J.
    Tu, S-M.
    McQuade, J. L.
    Fogelman, D.
    Starbuck, M. W.
    Subudhi, S. K.
    Corn, P.
    Pilie, P. G.
    Aparicio, A.
    Logothetis, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S538 - S538
  • [3] Clinical and genomic hallmarks of low PSA secretors in metastatic castration-resistant prostate cancer (mCRPC).
    Romero, Gustavo Rubio
    Weinstein, Alana
    Friedl, Verena
    Foye, Adam
    Playdle, Denise
    Sabol, Alexis
    Li, Patricia
    Huang, Jiaoti
    Feng, Felix Y.
    Stuart, Joshua M.
    Small, Eric Jay
    Aggarwal, Rahul Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Bilusic, Marijo
    Karzai, Fatima
    Cordes, Lisa M.
    Strauss, Julius
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Karzai, Fatima
    Cordes, Lisa M.
    Schlom, Jeffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [6] Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide
    Baciarello, Giulia
    Sternberg, Cora N.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 106 : 14 - 24
  • [7] BURDEN OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) IN TURKEY
    Erdal, E.
    Malhan, S.
    Oksuz, E.
    Benekli, M.
    Cag, C.
    Dane, F.
    Kabasakal, L.
    Kucuk, O.
    Sozen, T. S.
    Sar, C.
    Kahveci, B.
    VALUE IN HEALTH, 2016, 19 (07) : A725 - A726
  • [8] Testosterone levels in metastatic castration-resistant prostate cancer (mCRPC).
    von Klot, Christoph A. J.
    Boeker, Alena
    Herrmann, Thomas R. W.
    Kramer, Mario W.
    Kuczyk, Markus A.
    Merseburger, Axel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [9] Impact of combined lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC)
    Mak, B.
    Lin, H-M.
    Kwan, E. M.
    Fettke, H.
    Tran, B.
    Davis, I. D.
    Mahon, K. L.
    Stockler, M. R.
    Briscoe, K.
    Marx, G. M.
    Kohli, M.
    Tan, W.
    Huynh, K.
    Du, P.
    Yu, J.
    Jia, S.
    Joshua, A. M.
    Azad, A. A.
    Meikle, P. J.
    Horvath, L. G.
    ANNALS OF ONCOLOGY, 2021, 32 : S642 - S643
  • [10] Genomic characteristics associated with clinical activity of rucaparib in patients (pts) with BRCA1 or BRCA2 (BRCA)-mutated metastatic castration-resistant prostate cancer (mCRPC)
    Abida, Wassim
    Campbell, David
    Patnaik, Akash
    Sautois, Brieuc
    Shapiro, Jeremy David
    Vogelzang, Nicholas J.
    Bryce, Alan Haruo
    McDermott, Raymond S.
    Ricci, Francesco
    Rowe, Julie Haewon
    Zhang, Jingsong
    Loehr, Andrea
    Despain, Darrin
    Dowson, Melanie
    Golsorkhi, Tony
    Chowdhury, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)